Elutia (ELUT) Return on Capital Employed (2020 - 2026)
Elutia (ELUT) posted Return on Capital Employed of 79.85% for Q1 2026, up 41.73% sequentially from 137.04% in Q4 2025, and up 362531.0% YoY from N/an in Q1 2025.
Elutia (ELUT) Return on Capital Employed (2020 - 2026) Analysis & Trends
Elutia has reported Return on Capital Employed for 7 years, with the latest figure at 79.85% in Q1 2026.
- Quarterly Return on Capital Employed rose 362531.0% year-over-year to 79.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 79.85% (up 362531.0% YoY) and the FY2025 annual result came in at 111.67%, up 143749.0% from the prior year.
- Return on Capital Employed improved to 79.85% in Q1 2026 per ELUT's latest filing, from 137.04% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 2797.28% in Q2 2024 and troughed at 3705.17% in Q1 2025.
- A 5-year average of 230.18% and a median of 150.55% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2026: Return on Capital Employed slumped 215906 bps in 2024, then soared 362531 bps in 2026.
- Over 5 years, Return on Capital Employed stood at 150.55% in 2022, then slumped by 240 bps to 511.6% in 2023, then slumped by 47 bps to 751.83% in 2024, then soared by 82 bps to 137.04% in 2025, then jumped by 42 bps to 79.85% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 79.85%, 137.04%, and 302.06% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.08% |
| 10 | Elutia | 40.75 Mn | 20.85 Mn | 1.45 Mn | -91.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.85% |
| Dec 31, 2025 | -137.04% |
| Sep 30, 2025 | 302.06% |
| Jun 30, 2025 | 2,421.61% |
| Mar 31, 2025 | -3,705.17% |
| Dec 31, 2024 | -751.83% |
| Sep 30, 2024 | -632.99% |
| Jun 30, 2024 | 2,797.28% |
| Mar 31, 2024 | -2,309.26% |
| Dec 31, 2023 | -511.60% |
| Sep 30, 2023 | -361.83% |
| Jun 30, 2023 | -243.47% |
| Mar 31, 2023 | -150.20% |
| Dec 31, 2022 | -150.55% |
| Sep 30, 2022 | -189.82% |
| Jun 30, 2022 | -137.90% |
| Mar 31, 2022 | -72.47% |
| Dec 31, 2021 | -61.36% |
| Sep 30, 2021 | -45.48% |
| Jun 30, 2021 | -30.91% |